DC’s body-horror movie Clayface took the top spot at the North American box office this past weekend, but the debate afterward was about more than the ranking. The Clayface box office total was modest by superhero standards, yet audiences liked what they saw. So is this a stumble or a quiet success? The numbers give a more balanced answer than the headlines.
The opening in numbers
According to studio estimates reported by Deadline and the Associated Press, Warner Bros.’ Clayface earned about $24 million domestically from 3,458 theaters, edging out the A24 documentary You Can See Everything. It added roughly $19 million overseas, bringing the global debut to around $43 million.
That is not a big number next to the biggest superhero launches. One outlet noted that it was among the lower openings for a DC film in recent years. But the numbers need context, because the film’s budget was also small.
A small budget changes the picture
Reports put the budget at around $44 million, with some outlets citing a range of $30 million to $44 million. That is far below the cost of most comic-book blockbusters, which often run well past $150 million.
The film is R-rated horror based on a Batman villain, which limits the audience compared with a family-friendly release. A film like this does not need to match a mega-franchise opening to make money. If it holds well in the coming weeks, a modest opening could still lead to a profit once streaming and home entertainment revenue are added. Analysts quoted in the coverage said the second weekend would reveal more than the first.
What audiences and critics said
The audience reaction was strong. Clayface earned an A- CinemaScore, which is high for a horror movie. That grade often points to good word of mouth, which can help a film’s second and third weekends.
Critics were more divided. IGN gave it 7 out of 10, while Dread Central’s reviewer gave it three out of five and called it a mixed bag of body horror and uneven tone. Another review called it uninspired and too light on scares. That split is common for genre films, where fans and reviewers do not always agree.
The story behind the movie
The film stars Tom Rhys Harries as Matt Hagen, an actor who undergoes experimental facial surgery after being disfigured by a mob boss. It is DC’s third theatrical release under the leadership of James Gunn and Peter Safran, and it leans toward horror rather than the usual superhero spectacle.
That choice is part of the story. DC is testing whether smaller, genre-driven films can sit alongside its big team-up movies, and early signs suggest there is an audience for the experiment.
The takeaway
The Clayface box office result is not a blockbuster, but it is not a disaster either. A low budget, a first-place finish and a warm audience score suggest a film that could finish in the black. The next two weekends will show whether word of mouth can turn a modest debut into a steady run.
Figures are studio estimates from press reports and may change when final numbers are released.
